Latest News
Young people living with HIV should take their HIV medicines daily, according to the BREATHER+ trial
BREATHER+ results published in The Lancet HIV confirm that taking HIV medicines every day without breaks remains the best way to keep the virus under control.
Hormone patches are as effective as injections for treating non-metastatic prostate cancer
Evidence from the PATCH and STAMPEDE trial networks broadens treatment options for people with prostate cancer who are starting long-term hormone therapy.
Advanced imaging tools could help detect tuberculosis earlier
New findings from UCL and University of Cape Town show that PET-CT scans and AI-read X-Rays can detect evidence of TB in the lungs as much as 5 years before final diagnosis.
Severely malnourished children can safely take standard oral rehydration
These results from the GASTROSAM trial could lead to a review of the existing treatment rehydration guidelines for children who are suffering severe acute malnutrition.
Two medicines are as good as current three-medicine combinations to treat children living with HIV
Results from the D3 (Penta 21) trial presented at CROI show that using dolutegravir and lamivudine is safe and as effective as using a combination of three HIV medicines, to keep the virus under control.